Canada markets open in 3 hours 22 minutes

United-Guardian, Inc. (UG)

NasdaqGM - NasdaqGM Delayed Price. Currency in USD
Add to watchlist
7.76+0.08 (+0.98%)
At close: 04:00PM EDT
7.98 +0.22 (+2.90%)
After hours: 04:47PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close7.68
Open7.79
Bid7.50 x 1200
Ask7.81 x 100
Day's Range7.63 - 7.88
52 Week Range5.79 - 10.25
Volume5,091
Avg. Volume9,919
Market Cap35.629M
Beta (5Y Monthly)0.72
PE Ratio (TTM)13.85
EPS (TTM)0.56
Earnings DateMay 09, 2024 - May 13, 2024
Forward Dividend & Yield0.35 (4.51%)
Ex-Dividend DateFeb 09, 2024
1y Target EstN/A
  • GlobeNewswire

    United-Guardian Reports 2023 Financial Results

    HAUPPAUGE, N.Y., March 22, 2024 (GLOBE NEWSWIRE) -- United-Guardian, Inc. (NASDAQ:UG) reported that net income for FY 2023 remained relatively flat compared to FY 2022. Net sales for the year decreased by 14% from $12,698,503 in 2022 to $10,885,154 in 2023, generating net income of $2,581,370 ($0.56 per share) in 2023 compared to $2,569,512 ($0.56 per share) in 2022. Donna Vigilante, President of United-Guardian, stated, “While net income remained flat from 2022 to 2023, we did experience a decr

  • GlobeNewswire

    United-Guardian Announces Dividend Increase

    HAUPPAUGE, N.Y., Feb. 02, 2024 (GLOBE NEWSWIRE) -- United-Guardian, Inc. (NASDAQ:UG) announced today that the company's Board of Directors, at its meeting on January 30, 2024, declared a cash dividend of $0.25 per share, to be paid on February 20, 2024, to all stockholders of record as of the close of business on February 12, 2024. This will be the 29th consecutive year that the company has paid a dividend. Donna Vigilante, President of United-Guardian, stated, “I am pleased to report that the c

  • GlobeNewswire

    United-Guardian Appoints New Director

    HAUPPAUGE, N.Y., Jan. 08, 2024 (GLOBE NEWSWIRE) -- United-Guardian, Inc. (NASDAQ:UG), a manufacturer of cosmetic ingredients, pharmaceuticals, and medical lubricants, announced today that the company’s Board of Directors has appointed Catherine Joy Kolinski as the company’s newest director. Ms. Kolinski has more than 30 years of experience in the personal care, pharmaceutical and industrial sectors. She has a Bachelor of Science degree in chemistry, completed additional graduate course work in B